nVerses Capital LLC bought a new position in Inari Medical, Inc. (NASDAQ:NARI) in the second quarter, according to its latest 13F filing with the Securities and Exchange Commission.
The Rosen Law Firm, an international law firm representing investor rights, is reminding buyers of Inari Medical, Inc. common stock about a specific period of stock purchases.
Contact Hagens Berman before the July 12, 2024 deadline to participate in the class action lawsuit against Inari Medical (NARI).
Law Offices of Howard G. Smith is reminding investors that class action lawsuits have been filed on behalf of shareholders of certain companies.
Former Louisiana Attorney General reminds investors who have lost more than $100,000 about the deadline for lead plaintiff in the class action lawsuit against Inari Medical.
NARI investors can take the lead in the securities fraud lawsuit against Inari Medical, Inc.
The law firm Rosen Law Firm is reminding buyers of Inari Medical, Inc. common stock purchased between February 24 that they have investor rights.
Hagens Berman is encouraging investors who have suffered significant losses in Inari Medical, Inc. (NASDAQ: NARI) to reach out to the firm.
Former Louisiana Attorney General, Kahn Swick & Foti, LLC is reminding investors who have suffered losses exceeding $100,000 about the upcoming deadline to participate as a lead plaintiff in a class action lawsuit against Inari Medical.
Stay updated with the latests analysis and insights fromm etfsector.com